Mobile Menu - OpenMobile Menu - Closed


#EndRxMonopolyPrices: A Bold, Market-Driven Plan to Lower Prescription Drug Prices

July 24, 2018

***Media Advisory***

For Immediate Release

July 24, 2018

Contact: Kate Stotesbery

 (202) 225-4865

#EndRxMonopolyPrices: A Bold, Market-Driven Plan to Lower Prescription Drug Prices

Washington, DC – Tomorrow, Wednesday, July 25, join Reps. Doggett, Welch, and Cummings as they unveil new legislation to address the prescription drug affordability crisis: The Medicare Negotiation and Competitive Licensing Act. As Republicans continue to fail to address soaring healthcare costs and even promote health tax shelters for the well-off this week, they ignore the needs of working families. One of the top healthcare concerns for Americans is skyrocketing prescription drug prices—and the number one measure that Americans support to rein in those costs is Medicare negotiation. 

Today, these members are offering the plan that Americans have been demanding: A bold approach to Medicare negotiation that harnesses the government’s purchasing power and relies on market-driven competition to restrain monopoly pricing. Hear directly from a patient affected by soaring prescription drug prices, experts endorsing this plan, and the Members of Congress introducing this proposal to rein in prescription drug costs.


Rep. Lloyd Doggett

Rep. Peter Welch

Rep. Elijah Cummings

Public Citizen President, Rob Weissman

Social Security Works President, Nancy J. Altman

Patient Affected by Soaring Drug Prices


Tomorrow, Wednesday July 25, 2018, 11 AM EST


Rayburn House Office Building

Room 2247



Follow Lloyd Doggett | Twitter: @RepLloydDoggett |  Instagram: @RepLloydDoggett